Player FM ऐप के साथ ऑफ़लाइन जाएं!
Carlos Fernández de Larrea and Damian Green on BCMA CAR T cells in multiple myeloma
Manage episode 367799491 series 2829082
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00246-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 एपिसोडस
Manage episode 367799491 series 2829082
Carlos Fernández de Larrea (Hospital Clínic de Barcelona, Barcelona, Spain) and Damian Green (Fred Hutch Cancer Center, Seattle, WA, USA) discuss their studies on BCMA CAR T cells in patients with relapsed or refractory multiple myeloma.
Read the full article:
https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00246-2/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc
Tell us what you thought about this episode
Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
206 एपिसोडस
모든 에피소드
×![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Ian Tannock on Common Sense Oncology principles for phase 3 randomised clinical trials 18:03
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Yannick Romero on the changing landscape of national cancer control plans 24:40
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 M Saiful Huq and Mostafa Aziz Sumon on the series Cancer Care in South Asian Association for Regional Cooperation (SAARC) Countries 22:15
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Steven Horwitz on valemetostat for relapsed or refractory T-cell lymphoma 15:07
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Zachary Zumsteg on early phase trial design for novel drug-radiotherapy combination 17:21
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 May Abdel-Wahab and Andrew Scott on The Lancet Oncology Commission on Radiotherapy and Theranostics 40:45
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Kanwal Raghav on trastuzumab deruxtecan in HER2-positive advanced colorectal cancer (DESTINY-CRC02) 13:22
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Emmy Boerrigter on dose selection of novel anticancer drugs 11:41
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Hisham Mehanna and Sue Yom on head and neck cancer consensus recommendations 36:56
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Garth Strohbehn and Katie Lichter on the environmental impact of cancer treatment 24:08
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 James Shultz, Ana Patricia Ortiz, and Leticia Nogueira on cancer and compounding disasters in the Caribbean 35:05
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Bernardo Goulart on correlations of endpoints in lung cancer immunotherapy trials 11:22
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Maria Kyrgiou on innovations in gynaecological cancers and global disparities 25:42
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Georgios Lyratzopoulos on the use of chemotherapy and radiotherapy in patients with eight common cancers 34:43
![The Lancet Oncology in conversation with podcast artwork](/static/images/64pixel.png)
1 Mike Sathekge on radioligand therapy of metastatic castration-resistant prostate cancer 16:06
प्लेयर एफएम में आपका स्वागत है!
प्लेयर एफएम वेब को स्कैन कर रहा है उच्च गुणवत्ता वाले पॉडकास्ट आप के आनंद लेंने के लिए अभी। यह सबसे अच्छा पॉडकास्ट एप्प है और यह Android, iPhone और वेब पर काम करता है। उपकरणों में सदस्यता को सिंक करने के लिए साइनअप करें।